• Medientyp: E-Artikel
  • Titel: Safety of Bariatric Surgery in ≥ 65-Year-Old Patients During the COVID-19 Pandemic
  • Beteiligte: Singhal, Rishi; Omar, Islam; Madhok, Brijesh; Rajeev, Yashasvi; Graham, Yitka; Tahrani, Abd A.; Ludwig, Christian; Wiggins, Tom; Mahawar, Kamal; Pędziwiatr, Michał; Major, Piotr; Zarzycki, Piotr; Pantelis, Athanasios; Lapatsanis, Dimitris P.; Stravodimos, Georgios; Matthys, Chris; Focquet, Marc; Vleeschouwers, Wouter; Spaventa, Antonio G.; Zerrweck, Carlos; Vitiello, Antonio; Berardi, Giovanna; Musella, Mario; Sanchez-Meza, Alberto; [...]
  • Erschienen: Springer Science and Business Media LLC, 2022
  • Erschienen in: Obesity Surgery
  • Sprache: Englisch
  • DOI: 10.1007/s11695-022-06067-z
  • ISSN: 1708-0428; 0960-8923
  • Schlagwörter: Nutrition and Dietetics ; Endocrinology, Diabetes and Metabolism ; Surgery
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Age ≥ 65 years is regarded as a relative contraindication for bariatric surgery. Advanced age is also a recognised risk factor for adverse outcomes with Coronavirus Disease-2019 (COVID-19) which continues to wreak havoc on global populations. This study aimed to assess the safety of bariatric surgery (BS) in this particular age group during the COVID-19 pandemic in comparison with the younger cohort.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We conducted a prospective international study of patients who underwent BS between 1/05/2020 and 31/10/2020. Patients were divided into two groups — patients ≥ 65-years-old (Group I) and patients &lt; 65-years-old (Group II). The two groups were compared for 30-day morbidity and mortality.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 149 patients in Group 1 and 6923 patients in Group II. The mean age, preoperative weight, and BMI were 67.6 ± 2.5 years, 119.5 ± 24.5 kg, and 43 ± 7 in Group I and 39.8 ± 11.3 years, 117.7±20.4 kg, and 43.7 ± 7 in Group II, respectively. Approximately, 95% of patients in Group 1 had at least one co-morbidity compared to 68% of patients in Group 2 (<jats:italic>p</jats:italic>= &lt; 0.001).</jats:p><jats:p>The 30-day morbidity was significantly higher in Group I (11.4%) compared to Group II (6.6%) (<jats:italic>p</jats:italic>= 0.022). However, the 30-day mortality and COVID-19 infection rates were not significantly different between the two groups.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Bariatric surgery during the COVID-19 pandemic is associated with a higher complication rate in those ≥ 65 years of age compared to those &lt; 65 years old. However, the mortality and postoperative COVID-19 infection rates are not significantly different between the two groups.</jats:p></jats:sec><jats:sec><jats:title>Graphical abstract</jats:title></jats:sec>